Yüklüyor......
Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
Ovarian cancer is the 5th most common cancer in UK women with a high relapse rate. The overall survival for ovarian cancer has remained low for decades prompting a real need for new therapies. Recurrent ovarian cancer remains confined in the peritoneal cavity in >80% of the patients, providing an...
Kaydedildi:
| Yayımlandı: | Porto Biomed J |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726300/ https://ncbi.nlm.nih.gov/pubmed/31595233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.0000000000000007 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|